30
/fr/
AIzaSyAYiBZKx7MnpbEhh9jyipgxe19OcubqV5w
June 15, 2024
5819813
551854
1
Public Timelines FAQ
Public TimelinesFAQ
Public TimelinesFAQ
For educational institutions For teachers For students Open cabinet
For educational institutions For teachers For students Open cabinet
Créer
Create a timeline
Public timelines
Library
FAQ

21 juill. 2020 - AstraZeneca’s Phase I/II clinical trial for AZD1222 demonstrated a robust immune response (neutralizing antibody levels).

Ajouté au bande de temps:

COVID 2020 - Policy, vaccines, therapies, and testing

ByMedicalGold.ca
16 sept. 2021
0
0
569

Date:

21 juill. 2020
Maintenaint
~ Il y a 3 ans et 10 mois
About & FeedbackUn accordConfidentialitéBibliothèque
2024 © Time.Graphics
Support 24/7  
CabinetGet premium
Donate
The service accepts bank transfer (ACH, Wire) or cards (Visa, MasterCard, etc). Processed by Stripe.
Secured with SSL
Excellent (Trustpilot Reviews)
Based on 115+ reviews